ZEMANOVÁ, Jana, Kamil PARUCH, Lumír KREJČÍ, Karel SOUČEK, Ondřej HYLSE, Miroslav BOUDNÝ, Marek BORSKÝ, Jitka OSIČKOVÁ, PrashantKumar KHIRSARIYA, Ludmila ŠEBEJOVÁ, Veronika NAVRKALOVÁ, Jitka MALČÍKOVÁ, Eva DIVÍŠKOVÁ, Yvona BRYCHTOVÁ, Jiří MAYER and Martin TRBUŠEK. Chronic lymphocytic leukemia cells are highly susceptible to direct inhibition of checkpoint kinase. In 20th Congress of the European Hematology Association in Haematologica. 2015.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Chronic lymphocytic leukemia cells are highly susceptible to direct inhibition of checkpoint kinase
Authors ZEMANOVÁ, Jana, Kamil PARUCH, Lumír KREJČÍ, Karel SOUČEK, Ondřej HYLSE, Miroslav BOUDNÝ, Marek BORSKÝ, Jitka OSIČKOVÁ, PrashantKumar KHIRSARIYA, Ludmila ŠEBEJOVÁ, Veronika NAVRKALOVÁ, Jitka MALČÍKOVÁ, Eva DIVÍŠKOVÁ, Yvona BRYCHTOVÁ, Jiří MAYER and Martin TRBUŠEK.
Edition 20th Congress of the European Hematology Association in Haematologica, 2015.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Confidentiality degree is not subject to a state or trade secret
Organization unit Central European Institute of Technology
Tags International impact, Reviewed
Changed by Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 31/10/2015 14:30.
Links
MUNI/A/1180/2014, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit II (Acronym: VýDiTeHeMa II)
Investor: Masaryk University, Category A
NT13519, research and development projectName: Časná identifikace CLL pacientů s dosud nevyselektovanými mutacemi v proteinu p53
PrintDisplayed: 20/7/2024 20:32